Skip to main navigation Skip to search Skip to main content

Involvement of the HIF-1α and wnt/β-catenin pathways in the protective effects of losartan on fatty liver graft with ischaemia/reperfusion injury

  • Ying Ying Yang*
  • , Pei Chang Lee
  • , Yi Tsau Huang
  • , Wei Ping Lee
  • , Ying Ju Kuo
  • , Kuei Chuan Lee
  • , Yun Cheng Hsieh
  • , Tzung Yan Lee
  • , Han Chieh Lin
  • *Corresponding author for this work
  • Veterans General Hospital-Taipei
  • National Yang Ming Chiao Tung University
  • National Research Institute of Chinese Medicine Taiwan

Research output: Contribution to journal › Journal Article › peer-review

24 Scopus citations

Abstract

Besides cardioprotective effects, the AT1R (angiotensin-II type 1 receptor) antagonist losartan protects the liver from IRI [IR (ischaemia/reperfusion) injury], but the mechanism has not been fully determined. The HIF (hypoxia inducible factor)-1α and Wnt/β-catenin signalling pathways have been reported to be involved in the mechanism of liver IRI. Therefore the aim of the present study was to determine whether the Wnt/HIF axis is part of the mechanism of the positive effect of AngII inhibition by losartan in liver IRI in rats. Various measurements were made in MCD/HF-NASH (methionine- and choline-deficient-diet/high-fat-diet-induced non-alcoholic steatohepatitis) rats with liver IRI. Acute losartan pre-administration markedly reversed the IR-suppressed levels of the hepatic-protective factors IL (interleukin)-6, IFN (interferon)λ , Wnt3a, β-catenin and HIF-1a, and decreased hepatic blood flow and IR-elevated serum ALT (alanine aminotransferase), hepatic TNF (tumour necrosis factor)-a, IL-1a, hepatic congestion, vacuolization and necrosis, hepatic Suzuki IRI scores, necrotic index and levels of TBARS (thiobarbituric acid-reacting substances) in MCD/HF-NASH rats. Furthermore, acute Wnt3a pre-treatment significantly inhibited IR-elevated serum ALT, hepatic Suzuki IRI scores and TBARS, and restored the IR-depleted β-catenin/HIF-1a activity in MCD/HF-NASH rats. Simultaneous acute sFRP2 (secreted frizzled-related protein 2; a Wnt3a inhibitor) pre-treatment eliminated the losartan-related beneficial effects in MCD/HF-NASH rats with liver IRI, which was accompanied by a decrease in hepatic HIF-1a/β-catenin activity. Losartan-induced up-regulation of HIF-1α and Wnt/β-catenin signalling was associated with the recovery of IR-inhibited hepatic Bcl-2, Mn-SOD (manganese superoxide), Cu/Zn-SOD (copper/zinc superoxide) and GSH levels, and the suppression of IR-increased hepatic catalase and caspase 3/caspase 8 levels in MCD/HF-NASH rats. In conclusion, up-regulation of the HIF-1α and Wnt/β-catenin signalling pathways are part of the mechanism of the positive effects of losartan-related AngII inhibition in MCD/HF-NASH rats with liver IRI. Our study highlights the potential of the dual-organ protective agent losartan in NASH patients with steatotic livers and cardiovascular risk.

Original languageEnglish
Pages (from-to)163-174
Number of pages12
JournalClinical Science
Volume126
Issue number2
DOIs
StatePublished - 2014

Keywords

  • Angiotensin II type 1 receptor (AT1R)
  • Hypoxia-inducible factor-1α (HIF-1α)
  • Losartan
  • Steatotic liver
  • Wnt
  • β-catenin

Fingerprint

Dive into the research topics of 'Involvement of the HIF-1α and wnt/β-catenin pathways in the protective effects of losartan on fatty liver graft with ischaemia/reperfusion injury'. Together they form a unique fingerprint.

Cite this